journal
Evidence pageCell-Assisted Lipotransfer in Breast Augmentation Surgery: Clinical Outcomes and Considerations for Future Research
Cureus (via PubMed Central)
Published Mar 2, 2022accessed Sep 18, 2026Updated Sep 19, 2026
Original source
https://pmc.ncbi.nlm.nih.gov/articles/PMC8971120/
pmc.ncbi.nlm.nih.gov
Verification
| Verification | Not yet verified |
| Evidence level | — |
| Source | journal |
| Link status | Reachable at last check |
Official claims are statements by the provider; they are not verified by worldwiki unless marked otherwise. Source policy
Cited by (2)
FactSVF Breast Augmentation: Reported safety concerns = Cyst formation 6.9% with automated vs 1.6% with manual isolation in cited data; theoretical oncogenic concern from VEGF/FGF signalling; long-term oncologic data insufficientFactSVF Breast Augmentation: Method standardization = No standardized CAL protocol; multiple isolation systems in use (e.g., Celution, Medikhan, Fatstem, Mystem)